We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Scenario Analysis When Conducting Budget Impact Analyses for Rare Diseases.
- Authors
Borrelli, Eric P.; Leslie, R. Scott
- Abstract
Pharmacoeconomic analyses are an important and useful guide for understanding a pharmacotherapeutic intervention's financial impact for relevant stakeholders. One type of pharmacoeconomic analysis that assesses a pharmacotherapeutic intervention's short-term financial implications is a budget impact analysis. Although methodology guidelines for budget impact analyses in the United States currently exist, not much guidance is available for analyses that are being conducted of rare or ultrarare disease states. In this article, we propose conducting a scenario analysis for pharmacotherapeutic interventions to treat rare diseases by varying health plan sizes to indicate what the potential plan impact would be if 1 member in said health plan received treatment. We then walk through an illustrative example and discuss the rationale for it.
- Subjects
MEDICAL care costs; ECONOMICS; PHARMACEUTICAL services insurance; PHARMACEUTICAL industry; RARE diseases
- Publication
American Journal of Managed Care, 2022, Vol 28, Issue 10, pe351
- ISSN
1088-0224
- Publication type
Article
- DOI
10.37765/ajmc.2022.89252